HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

Benzinga · 1d ago
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.